Genomics Inform.  2013 Jun;11(2):68-75. 10.5808/GI.2013.11.2.68.

Recent Progress of Genome Study for Anaplastic Thyroid Cancer

• Lee J
• Hwang JA
• Lee EK

• KMID: 1494259
• DOI: http://doi.org/10.5808/GI.2013.11.2.68

Abstract

Anaplastic thyroid cancer (ATC) belongs to the most malignant and rapidly progressive human thyroid cancers and its prognosis is very poor. Also, it shows high resistance to cancer treatments, so that effective treatment for ATC has not been found to date, and virtually all patients terminate their life rapidly after diagnosis. Although targeted treatment of genetic alterations has emerged as an extremely promising approach to human cancers, such as BRAF in metastatic melanoma, it remains unclear that how commonly genomic alterations are influenced in ATC tumorigenesis. In recent years, genome wide approaches have been exploited to find genetic alterations associated with complex diseases, including cancer. Here, we reviewed the comprehensive genetic alterations in ATC and recent approaches in the context of identifying genomic alterations associated with ATC. Since surprisingly few reports have been published on the genome wide study of ATC, this review puts emphasis on the urgent needs of genomic research for the prevention and treatment of ATC.

Keyword

anaplastic thyroid cancer; disease associated alterations; genetic variation

MeSH Terms

Cell Transformation, Neoplastic
Genetic Variation
Genome
Humans
Melanoma
Prognosis
Thyroid Gland
Thyroid Neoplasms
Thyroid Neoplasms